While insulins have long been a treatment mainstay for diabetes, the development of peptide drugs from somatostatin [1], calcitonin [2], [3], parathyroid hormone (PTH) [4], vasopressin [5], and glucagon like peptide-2 (GLP-2) [6] classes have become important treatment options for metabolic indications. Here, PTH is linked to diabetes mellitus.